Even when used as directed by a doctor, people can have stomach and bowel side effects, including nausea, vomiting and constipation, especially when they start the drugs
Theyve been taking it without a prescription
These recommendations aim to optimize treatment outcomes while addressing potential risks and challenges unique to this population
Novo Nordisks highly anticipated phase 3 EVOKE and EVOKE+ trials evaluated oral semaglutide (Rybelsus), a GLP-1 receptor agonist, in 3,808 individuals with early-stage Alzheimers disease, aiming to slow cognitive decline over a 2-year period
This concentration offers good longevity at moderate doses, which is ideal for people who have found their effective dose and want to maintain it long-term without constantly reordering vials